Haplogen identifies novel host-factors of pathogens using their proprietary technology to develop therapeutics and to treat infectious diseases.

They use cell lines with only a single copy of each gene – thus they are haploid.

They provide a technology platform which is a rapid and reliable method to discover novel host factors.

Haplogen’s most advanced programme is in the area of virus caused diseases.

Haplogen GmbH
Campus-Vienna-Biocenter 3
1030 Vienna
Austria
Building: VBC3 – Map

+43 (0) 1 916 55 22